Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Ferritin Heavy Chain ELISA Kit (AC2824)
Cat.#: ASET-1413
Specifications
Description Rat Ferritin Heavy Chain ELISA Kit allows for the in vitro quantitative determination of rat Ferritin Heavy Chain concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 3.75 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 6.25-400 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1228 Human Plexin-B3 ELISA Kit (AC2639) Quantitative inquiry ASET-1961 Mouse Antidiuretic Hormone ELISA Kit (AC3372) Quantitative inquiry ASET-2020 Human Angiogenin ELISA Kit (AC3431) Quantitative inquiry ASET-1197 Human EMP3 ELISA Kit (AC2608) Quantitative inquiry ASET-2441 Camel Insulin ELISA Kit (AC3852) Quantitative inquiry ASET-2067 Rat GMFB ELISA Kit (AC3478) Quantitative inquiry ASET-1415 Mouse nNOS (neuronal) ELISA Kit (AC2826) Quantitative inquiry ASET-1671 Human KLC1 ELISA Kit (AC3082) Quantitative inquiry ASET-1487 Rat ABCA1 ELISA Kit (AC2898) Quantitative inquiry ASET-1087 Rat Dystrophin ELISA Kit (AC2498) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket